Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review.
about
Pharmacological interventions for cognitive decline in people with Down syndromePharmacological interventions for cognitive decline in people with Down syndromeSuccessful therapies for Alzheimer's disease: why so many in animal models and none in humans?Can angiotensin-converting enzyme inhibitors impact cognitive decline in early stages of Alzheimer's disease? An overview of research evidence in the elderly patient populationModifiable risk factors for Alzheimer disease and subjective memory impairment across age groups.Diabetes and the brain: issues and unmet needs.Advances in the prevention of Alzheimer's disease and dementiaHypertension and dementia in the elderly: the leisure world cohort study.Neuroprotection and neurodegeneration in Alzheimer's disease: role of cardiovascular disease risk factors, implications for dementia rates, and prevention with aerobic exercise in african americans.Risk Factors and Hospitalization Costs of Dementia Patients: Examining Race and Gender VariationsReduction of Long-Term Care Dependence After an 8-Year Primary Care Prevention Program for Stroke and Dementia: The INVADE Trial.A multimodal approach to dementia prevention: A report from the Cambridge Institute of Public Health.Influenza Vaccination Reduces Dementia Risk in Chronic Kidney Disease Patients: A Population-Based Cohort Study.The projected effect of risk factor reduction on Alzheimer's disease prevalence.Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementiaOptimising primary care for people with dementia.Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors.Impact of coronary heart disease on cognitive decline in Alzheimer's disease: a prospective longitudinal cohort study in primary care.Can we influence the epidemiology of dementia? Perspectives from population-based studies.Cognitive impairment and cardiovascular medication use: Results from Wave 1 of The Irish Longitudinal Study on Ageing.Determinants of Dropout and Nonadherence in a Dementia Prevention Randomized Controlled Trial: The Prevention of Dementia by Intensive Vascular Care Trial.Immunoadsorption of Agonistic Autoantibodies Against α1-Adrenergic Receptors in Patients With Mild to Moderate Dementia.Side chain-oxidized oxysterols regulate the brain renin-angiotensin system through a liver X receptor-dependent mechanismAssociation of cardiovascular system medications with cognitive function and dementia in older adults living in nursing homes in Australia.Time until incident dementia among Medicare beneficiaries using centrally acting or non-centrally acting ACE inhibitors.Cardiovascular risk management in community-dwelling elderly: opportunities for prevention.Modeling the effects of obstructive sleep apnea and hypertension in Vietnam veterans with PTSD.Protocol for a feasibility randomised controlled trial of Screening and Enhanced Risk management for Vascular Event-related Decline in Memory (SERVED Memory).Mild cognitive impairment, risk factors and magnetic resonance volumetry: role of probable Alzheimer's disease in the family.
P2860
Q24186316-9B0D0CF1-83A1-43A7-A4D8-8306DECF131AQ24188311-942007C9-191A-449C-922E-D89FFB401654Q26859305-BEF802F9-14C2-4DC6-A642-FF977741F05CQ28077087-E5EFCE85-4A75-4E5D-A684-7D40D6366678Q33712358-27B783E5-CD8C-465F-BE1A-184EB14D8629Q33780337-8B3C15F2-607D-4501-9ED7-604AA6368554Q35322167-F26C07C1-E8E1-4CE1-82C4-6589F3CB5C19Q35646388-D01A9E93-54D8-4980-B8CE-980BAB5B5FC9Q35936632-8929BC49-7C2D-472E-8E25-768E2543E30DQ36088321-7BF338C9-0D6F-42C0-A08B-1F7347209469Q36366307-3C4E3895-285E-4EF1-A5EE-48CBC0D633ABQ36572536-88BBA318-9F6C-4BD3-A58C-6BEF3A08C5BAQ36663903-DE41F7E6-DACF-4985-BD3E-06BB1C7DA448Q36825862-E2B39F90-126D-48C9-8FA6-F2DAED06F9B2Q36989228-37C77D1E-A764-4F15-A337-F3F786955311Q37294156-E7A05994-921B-4846-8014-A7C95AB31D1BQ37907924-10FA177A-F50F-4171-B729-CFAEAC6056C6Q38374783-A3477B5E-78D5-4CB4-9B03-3B3B82DF0160Q38577801-CA10C1DC-ACE0-43FC-B2C0-4C447EBB8D21Q38610602-AB071C80-EC53-4233-95A6-9A316C76B019Q38750156-E255C006-3A3D-43DD-8F96-099253BDCA03Q39837503-D94D868F-47FA-4EA9-9E7E-7C49BE97206EQ42821910-FDCBE311-550D-41B7-A20C-4BC2CA299C08Q42875420-13DD9083-E17D-4413-AA39-90EF745083CFQ43495509-8FE6298F-51EC-4D25-AB94-B7502D40F713Q44069618-1256B88F-07FD-4EC4-BD51-FDCFDA90403BQ45330332-E6C0BDB1-565E-48B6-9036-A311F0A808F8Q47149418-626174B9-A39D-4F5B-A8C1-3AB3F646C349Q50881899-F6FF0D4C-2CD1-40F3-B591-6A1EE6F7F325
P2860
Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Treatment of cardiovascular ri ...... dementia: a systematic review.
@ast
Treatment of cardiovascular ri ...... dementia: a systematic review.
@en
Treatment of cardiovascular ri ...... dementia: a systematic review.
@nl
type
label
Treatment of cardiovascular ri ...... dementia: a systematic review.
@ast
Treatment of cardiovascular ri ...... dementia: a systematic review.
@en
Treatment of cardiovascular ri ...... dementia: a systematic review.
@nl
prefLabel
Treatment of cardiovascular ri ...... dementia: a systematic review.
@ast
Treatment of cardiovascular ri ...... dementia: a systematic review.
@en
Treatment of cardiovascular ri ...... dementia: a systematic review.
@nl
P2093
P2860
P921
P356
P1476
Treatment of cardiovascular ri ...... dementia: a systematic review
@en
P2093
Edo Richard
Eric P Moll van Charante
Willem A Van Gool
P2860
P304
P356
10.2147/VHRM.S7343
P407
P577
2010-09-07T00:00:00Z